Serial 98431531
Live / Applied — Third extension granted (statement of use) (as of 23 Feb 2026)
What this means for you
Not registered yet, but its 04 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98431531
- Mark type
- Design / logo
- Filed
- 04 Mar 2024
- Published for opposition
- 03 Sept 2024
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparation, namely, a recombinant, human monoclonal antibody antigen-binding fragment designed to reverse the antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations.
Owner
- BTG International Inc., West Conshohocken, PA, US
- BTG International Inc., West Conshohocken, PA, US
Prosecution history
- 24 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Feb 2026 — SOU EXTENSION 3 GRANTED
- 23 Feb 2026 — SOU EXTENSION 3 FILED
- 23 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 19 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Sept 2025 — SOU EXTENSION 2 GRANTED
- 18 Sept 2025 — SOU EXTENSION 2 FILED
- 18 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Mar 2025 — SOU EXTENSION 1 GRANTED
- 12 Mar 2025 — SOU EXTENSION 1 FILED
- 12 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Sept 2024 — PUBLISHED FOR OPPOSITION